Kartik Shenoy

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma

Katherine N. Cahill, Howard R. Katz, Jing Cui et al. · New England Journal of Medicine · 2017 · 209 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 141 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction

A. James Mamary, Jeffery I. Stewart, Gregory L. Kinney et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2018 · 81 citations · Full text

Medicine, Genetics, Epidemiology +16

Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure

Kevin R. Murphy, Bradley E. Chipps, David A. Beuther et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 73 citations

Medicine, Preventive Medicine, Health Assessment +8